Champions Oncology Inc (NASDAQ: CSBR) stock closed at $8.30 on 9/15/25 after a major increase of 21.5%. Moreover, this advance was accompanied by exceptionally high trading volume at 612% of normal. The stock has been extremely weak relative to the market over the last nine months but has risen 21.3% during the last week.
Current PriceTarget Research Rating
Champions Oncology has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Champions Oncology has a very low Appreciation Score of 11 and a very low Power Rating of 7, producing the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment